fda takes tirzepatide off shortage list news october 18 2025 has announced that the of # tirzepatide, the ingredient in FDA Can Keep Tirzepatide off

MiraLAX is a gentle laxative designed to treat occasional constipation

Its no secret: GLP1 receptor agonistslike semaglutide, liraglutide, dulaglutidehave transformed metabolic and weightmanagement treatments

Investigators found GLP-1s are effective in helping kids and teens manage weight and diabetes, with no increase in serious mental health risks compared with placebo.

The findings add to the growing conversation around drug repurposing where existing medications reveal unexpected benefits

Conclusion Semaglutide treatment in eligible US adults may substantially reduce obesity prevalence and CVD events, which may dramatically impact associated healthcare costs.